title: A critical appraisal of pexelizumab treatment in patients undergoing coronary artery bypass grafting.
authors.forename: Gen-Min
authors.initials: GM
authors.lastname: Lin
authors.forename: Yi-Hwei
authors.initials: YH
authors.lastname: Li
authors.forename: Chih-Lu
authors.initials: CL
authors.lastname: Han
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001026:Coronary Artery Bypass / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced; D010974:Platelet Aggregation / Q000187:drug effects; D057127:Single-Chain Antibodies / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D057127:Single-Chain Antibodies; C402724:pexelizumab